Invention Grant
- Patent Title: Hexahydro-1H-4,7-methanoisoindole-1,3-dione compounds
- Patent Title (中): 六氢-1H-4,7-亚甲基异吲哚-1,3-二酮化合物
-
Application No.: US13590210Application Date: 2012-08-21
-
Publication No.: US08410111B2Publication Date: 2013-04-02
- Inventor: Mark T. Bilodeau , Kausik K. Nanda , B. Wesley Trotter
- Applicant: Mark T. Bilodeau , Kausik K. Nanda , B. Wesley Trotter
- Applicant Address: US NJ Rahway
- Assignee: Merck Sharp & Dohme Corp.
- Current Assignee: Merck Sharp & Dohme Corp.
- Current Assignee Address: US NJ Rahway
- Agent J. Eric Thies; Gerard M. Devlin
- Main IPC: A61K31/496
- IPC: A61K31/496 ; C07D417/12
Abstract:
The present invention is directed to therapeutic agents which are atypical antipsychotics and which are useful in the treatment of neurological and psychiatric disorders associated with dopamine D2 and serotonin 5-HT2A neurotransmission dysfunction.
Public/Granted literature
- US20120316181A1 HEXAHYDRO-1H-4,7-METHANOISOINDOLE-1,3-DIONE COMPOUNDS Public/Granted day:2012-12-13
Information query
IPC分类:
